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Background: In this study, a pH and temperature dual-sensitive liposome gel based on a 
novel cleavable hydrazone-based pH-sensitive methoxy polyethylene glycol 2000-hydrazone-
  cholesteryl hemisuccinate (mPEG-Hz-CHEMS) polymer was used for vaginal administration.
Methods: The pH-sensitive, cleavable mPEG-Hz-CHEMS was designed as a modified pH-
sensitive liposome that would selectively degrade under locally acidic vaginal conditions. The 
novel pH-sensitive liposome was engineered to form a thermogel at body temperature and to 
degrade in an acidic environment.
Results: A dual-sensitive liposome gel with a high encapsulation efficiency of arctigenin was 
formed and improved the solubility of arctigenin characterized by Fourier transform infrared 
spectroscopy and differential scanning calorimetry. The dual-sensitive liposome gel with 
a   sol-gel transition at body temperature was degraded in a pH-dependent manner, and was 
stable for a long period of time at neutral and basic pH, but cleavable under acidic conditions 
(pH 5.0). Arctigenin encapsulated in a dual-sensitive liposome gel was more stable and less 
toxic than arctigenin loaded into pH-sensitive liposomes. In vitro drug release results indicated 
that   dual-sensitive liposome gels showed constant release of arctigenin over 3 days, but showed 
sustained release of arctigenin in buffers at pH 7.4 and pH 9.0.
Conclusion: This research has shed some light on a pH and temperature dual-sensitive   liposome 
gel using a cleavable mPEG-Hz-CHEMS polymer for vaginal delivery.
Keywords: mPEG-Hz-CHEMS polymer, pH-sensitive liposomes, thermosensitive, liposome 
gel, vaginal delivery
Introduction
Arctigenin, a major bioactive component of Fructus arctii, occurs naturally in Bardanae 
fructus, Arctium lappa L., Saussurea medusa, Torreya nucifera, and Ipomea cairica. 
As a phenylpropanoid dibenzyl butyrolactone lignan, it has been reported to exhibit 
antioxidant, antihuman immunodeficiency virus, antitumor, and anti-inflammatory 
activity.1–5
Conventional vaginal delivery systems, such as creams, gels, tablets, and foams, 
are easily removed by the self-cleansing action of the vaginal tract. The efficacy of 
all of these treatments is limited by their residence time in the genitourinary tract.6 
Moreover, the physiology arising from the protective mechanism of the genitourinary 
tract limiting residence time and impairing therapeutic drug efficacy makes multiple 
and frequent administrations necessary for effective treatment.7   Uncomfortable vaginal 
delivery and the need for repeated dosing are challenges in terms of patient   compliance. 
To overcome these limitations, novel vaginal delivery systems (microspheres, 
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  bioadhesive gels, and tablets) have attracted considerable 
attention for prolonging drug contact with a mucosal surface 
without inducing local adverse effects on the epithelium.
Thermosensitive gel systems composed of   poloxamers 
are easily administered to the vagina without difficulty 
or leakage, and are retained in the vagina for a long time. 
  Furthermore, poloxamer gel formulations have been reported 
to produce significantly higher initial plasma concentrations 
and faster time to peak concentration values than a solid sup-
pository, indicating that a drug in poloxamer gel form could 
be absorbed more rapidly than the solid form. Poloxamer gel 
systems are more physically stable, convenient, and effective 
vaginal dosage formulations. Over the past few years, gels 
containing liposomes have been advocated in the literature 
as vaginal drug delivery systems.8,9 The purpose of these 
formulations is to maintain liposomes at the delivery site 
and to avoid their rapid clearance from the system in order 
to achieve sustained drug release.
Hydrazone-based pH-sensitive methoxy polyethyl-
ene   glycol 2000-hydrazone-cholesteryl hemisuccinate 
(mPEG2000-Hz-CHEMS) was synthesized and used to man-
ufacture liposomes in our previous research. This material 
was stable at pH 7.4 but sensitive to mild acidic conditions 
(pH 5.5). mPEG2000-Hz-CHEMS-modified paclitaxel-
containing pH-sensitive liposomes and the accelerated blood 
clearance phenomenon have also been investigated. However, 
further research on the use of mPEG2000-Hz-CHEMS in lipo-
some gels for vaginal delivery has not been reported. This is 
interesting and novel for the use of mPEG2000-Hz-CHEMS 
in the pH and temperature dual-sensitive vaginal liposome 
gel delivery system.10–12
In this study, a pH and temperature dual-sensitive 
mucoadhesive vaginal gel formulation was developed for 
gynecological purposes. A schematic diagram of the mPEG-
Hz-CHEMS cleavable dual-sensitive liposome gel strategy 
is shown in Figure 1. The pH-sensitive cleavable mPEG-Hz-
CHEMS was designed as a modified pH-sensitive liposome 
that would selectively degrade under locally acidic vaginal 
conditions. The novel pH-sensitive liposome was engineered 
to form a thermogel at body temperature and to degrade in an 
acidic environment. To this end, we prepared pH and tem-
perature dual-sensitive cleavable arctigenin-encapsulating 
liposome gels, composed of phosphatidylcholine, mPEG-Hz-
CHEMS, and cholesterol. The physicochemical properties of 
the pH-sensitive liposomes and the dual-sensitive liposome 
gel were characterized, and the in vitro release and cytotoxic-
ity of these arctigenin-encapsulated dual-sensitive liposome 
gels was investigated.
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Figure 1 A schematic diagram of the strategy of mPEG-Hz-CHEMS cleavable dual-sensitive 
liposome gels.
Abbreviation: mPEG-Hz-CHEMS, methoxy polyethylene glycol 2000-hydrazone-
cholesteryl hemisuccinate.
Materials and methods
Materials
Soybean phosphatidylcholine (S100PC) was purchased 
from Dongshang Co, Ltd (Shanghai, China). Cholesterol was 
obtained from China Medicine Shanghai Chemical Reagent 
Corporation (Shanghai, China). Arctigenin was supplied by 
Yantai Science and Biotechnology Co, Ltd (Yantai, China). 
mPEG2000-Hz-CHEMS were synthesized in our laboratory. 
All other chemicals were of analytical grade.
Preparation of pH-sensitive liposomes
pH-sensitive liposomes were prepared according to the 
thin-film hydration method. Briefly, a pH-sensitive lipid 
mixture of S100PC, DOPE, cholesterol, and mPEG2000-Hz-
CHEMS (molar ratio 5:3:1:1) was dissolved in chloroform. 
Arctigenin-loaded pH-sensitive liposomes were prepared by 
dissolving arctigenin in the organic phase of chloroform and 
methanol (1:3, v/v) and mixing with S100PC, DOPE, choles-
terol, and mPEG2000-Hz-CHEMS. The organic phase was 
removed at 40°C in a rotary flask. The flask was evaporated 
under reduced pressure. The dry lipid formed was hydrated 
with phosphate-buffered saline (pH 7.4). The liposomal 
suspension was filtered through 0.2 mm polycarbonate filters 
and stored at 4°C until use. Nonsensitive arctigenin-loaded 
liposomes without mPEG2000-Hz-CHEMS were also pre-
pared as the control.
Determination of entrapment efficiency
The particle size and zeta potential of the liposomes were 
measured and analyzed using a 3000H Zetasizer (Malvern 
Instruments, Worcestershire, UK). The entrapment effi-
ciency was defined as the ratio of the amount of arctigenin 
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  encapsulated in the liposome to that of the total arctigenin in 
the liposomal dispersion. The drug-loading rate is defined as 
the ratio of the amount of arctigenin encapsulated in the lipo-
some to that of the total number of freeze-dried   liposomes. 
An aliquot of liposome was treated with a 50-fold volume of 
methanol to disrupt the structure of the liposome. The amount 
of encapsulated arctigenin was measured using reverse-phase 
high-pressure liquid chromatography. The concentration of 
arctigenin in the liposomes was also determined by high-
pressure liquid chromatography (HP1100, Agilent, Santa 
Clara, CA). The mobile phase was a mixture of methanol 
and water (55:45 v/v). The column was a Kromasil C18 
(4.6 mm × 250 mm). The flow rate was 1.0 mL/minute, 
the detection wavelength was 280 nm (ultraviolet detector, 
HP1100, Agilent, USA), the column temperature was 30°C, 
and the volume of the sample injected was 20 µL.
The entrapment efficiency was determined from 
three separately prepared liposome suspensions as the 
mean ± standard deviation. The entrapment efficiency was 
calculated from the following equation:
  EE (%)
Amount of AC in liposome
Amount of total AC
100 =×
Preparation of pH and temperature  
dual-sensitive gel
Thermosensitive gels were prepared by addition of P188 and 
P407 at various ratios, as described previously.13 Briefly, 
various ratios of poloxamers were dissolved in distilled water 
and kept at 4°C until a clear solution was obtained. For dual-
  sensitive liposome gels, poloxamers were dissolved in pH-
sensitive liposome dispersions instead of distilled water. The 
gelation temperature was defined as the temperature at which 
the liquid phase makes a transition to gel.13 In brief, a 10 mL 
transparent vial containing a magnetic bar and each formulation 
was placed in a water bath. The vial was heated at a constant rate 
while stirring. The gelation temperature was measured when 
the magnetic bar stopped moving due to gelation.
Characterization of pH and temperature 
dual-sensitive gels
Fourier transform infrared spectrophotometry
Functional group characterization was carried out by   Fourier 
transform infrared analysis using a Fourier transform infrared 
spectrometer (Travel IR, Danbury, CT, US SensIR Technolo-
gies, Danbury, CT). The samples were prepared by compress-
ing the free drug, lyophilized arctigenin, arctigenin-loaded 
pH-sensitive   liposomes, and arctigenin-loaded dual-sensitive 
liposome gel into pellets with potassium bromide.
Differential scanning calorimetry
Formation of the blank gel, arctigenin-loaded pH-sensitive 
liposomes, and arctigenin-loaded dual-sensitive liposome 
gel was confirmed by differential scanning calorimetry. Each 
sample, weighing 3 mg, was heated in hermetically sealed 
aluminum pans at a rate of 10°C per minute up to 250°C in 
a dynamic nitrogen atmosphere. All samples were analyzed 
in duplicate.
Measurement of gelation temperature
Gelation temperature was defined as the temperature at 
which the liquid phase makes a transition to gel, as described 
  previously.13 In brief, one milliliter of each polymer solution 
was transferred to each 4 mL vial, and the vials were kept at 
4°C overnight. The vials were then placed in a water bath and 
equilibrated at 15°C for 15 minutes. The sol-gel and gel-sol 
transitions of the polymer solutions were tested using the tube 
inversion method in the temperature range of 15°C–80°C, 
while the polymer solutions were heated at a rate of 2°C every 
5 minutes.14 The transition temperature at which a polymer 
solution stopped flowing after tube inversion was recorded 
as the gelation temperature.
pH-sensitive gel test
pH-sensitive liposomes were prepared at a concentration of 
20% in phosphate-buffered saline (pH 7.4). A 1 mL aliquot of 
polymer solution was placed in a series of 5 mL vials, and the 
vials were kept at 4°C overnight. Later, the polymer solutions 
were incubated at 37°C for 10 minutes for gelation. After 
gelation, 3 mL of phosphate buffer (pH 5.0, 7.4, and 9.0) 
was added to the vials. After gel erosion for a predetermined 
time, the weights of the gels were measured.
In vitro drug release
The in vitro release of arctigenin from different vaginal 
gels was determined using a dialysis bag placed in a sealed 
glass vial under constant shaking. One gram of each gel 
formulation (500 µg of arctigenin) was packed into the 
dialysis bags sealed with closures of 50 mm. The dialysis 
bags containing arctigenin-loaded dual-sensitive liposome 
gel were placed in a water bath at 37°C until the gel formed. 
The release medium was 45 mL of 0.1 M phosphate buffer 
(pH 5, 7.4, and 9), providing sink conditions for   arctigenin. 
The medium was maintained at 37°C and shaken at 
100 rpm. At various time intervals, 1 mL of dissolution fluid 
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was collected. The sample filtrate was analyzed by reverse-
phase high-pressure liquid   chromatography. The mobile 
phase was a mixture of methanol and water (55:45 v/v). 
The column was a Kromasil C18 (4.6 mm × 250 mm). The 
flow rate was 1.0 mL/minute, the detection wavelength 
was 280 nm (ultraviolet detector, HP1100, Agilent), the 
column temperature was 30°C, and the injected volume of 
the sample was 20 µL.
Cytotoxicity assay
To evaluate the cytotoxicity of the arctigenin gel by MTT 
assay, HEK293 cells were seeded at a density of 1 × 104 cells/
well in a 96-well plate overnight. A 100 µL aliquot of arcti-
genin solution (0.8 mg/mL), arctigenin-loaded pH-sensitive 
liposomes, arctigenin-loaded dual-sensitive liposome gel, 
diluted arctigenin-loaded dual-sensitive liposome gel (1:2, 
1:4 in phosphate-buffered saline), and free arctigenin in 
diluted gel (1:4 in phosphate-buffered saline) were added to 
each well and incubated overnight; positive controls (80 µg 
as arctigenin) and negative controls (phosphate-buffered 
saline alone) were placed in additional wells and incubated 
overnight. After incubation, 100 µL of 5 mg/mL MTT in 
Dulbecco’s Modified Eagle’s Medium was added to each well 
and incubated for 4 hours at 37°C. To dissolve the formazan 
crystal, 100 µL of MTT solubilization solution was added. 
After shaking the 96-well plate for 30 minutes, absorbance 
was measured at 570 nm using a microplate reader.
Statistical analysis
Statistical comparisons were performed using the Student’s 
t-test for two groups, and one-way analysis of variance for 
multiple groups. P , 0.05 was considered to be indicative 
of statistical significance.
Results and discussion
Characteristics of mPEG-Hz-CHEMS-
modified pH-sensitive liposomes
If the arctigenin-loaded dual-sensitive liposome gel was 
applied to the vaginal membrane, the liposomes or drug 
released would be taken up into the cells and tissues 
of the vaginal membrane. Thus, the particle size, zeta 
potential, and entrapment efficiency of liposomes would 
be important factors for vaginal delivery of the drug. The 
structure and 1H-NMR spectrum of the mPEG-Hz-CHEMS 
is shown in Figure 2. As shown in Table 1, the mean 
particle size of arctigenin-loaded pH-sensitive liposomes 
was 126.6 ± 3.8 nm. The mean zeta potential was about 
−18.1 ± 2.3 mV. The entrapment efficiency was determined 
to be above 90%.
Characterization of dual-sensitive 
liposome gel
Formation of dual-sensitive liposome gel was confirmed using 
different techniques, including Fourier transform infrared 
spectrophotometry and differential scanning calorimetry. 
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Figure 2 The structure and 1H-NMR spectra of mPEG-Hz-CHEMS in CDCl3.
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Table  1  The  physicochemical  parameters  of  AC-loading  pH-
sensitive liposomes and plain AC liposomes
Parameters Plain liposomes pH-sensitive 
liposomes
Entrapment efficiency (%)   88.9 ± 4.4   93.8 ± 3.2
Particle size (nm) 118.9 ± 5.6 126.6 ± 3.8
Zeta potential (mv) −21.9 ± 2.6 −18.1 ± 2.3
Abbreviation: AC, arctigenin.
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Figure 3 (Continued)
  Figure 3 shows the Fourier transform infrared spectra for blank 
gel (A), arctigenin-loaded pH-sensitive liposomes (B), and arc-
tigenin-loaded pH-sensitive liposome gel (C). It can be clearly 
observed that the arctigenin-loaded pH-sensitive liposome 
showed a sharp C=O stretch band at 1740 cm−1. In the case of 
the arctigenin-loaded pH-sensitive liposome gel, the carbonyl-
stretching band of the drug disappeared, which suggested that 
the arctigenin-loaded pH-sensitive liposome was involved in 
the gel. The differential scanning calorimetry thermograms 
shown in Figure 4 indicate the thermal behavior of free arcti-
genin (A), arctigenin-loaded pH-sensitive liposomes (B), and 
arctigenin-loaded pH-sensitive liposome gel (C) in a range of 
30°C–280°C. The arctigenin-loaded pH-sensitive liposomes 
and arctigenin-loaded pH-sensitive liposome gel show peaks 
at about 48°C in the differential scanning calorimetry curve. 
However, complete disappearance of the endothermic peak 
corresponding to arctigenin was seen for arctigenin-loaded 
pH-sensitive liposomes and arctigenin-loaded pH-sensitive 
liposome gel, indicating molecular encapsulation of the arc-
tigenin inside the liposomes and gel.
Arctigenin-loaded dual-sensitive liposome gel was 
prepared using P407:P188 at various ratios. With the tem-
perature-sensitive P407 and P188 gelling polymers, the con-
centration of poloxamers (P407:P188, 12:20, or 15:15 w/w%) 
was previously demonstrated to form gels,13,15 and gelling 
temperatures were lowered by increasing the amount of 
P188 at an equal content of P407. Figure 5 shows the sol-
gel transition of arctigenin dual-sensitive gels over gelation 
temperature (A), at gelation temperature (B), and under 
gelation temperature (C). In the absence of pH-  sensitive 
liposomes, the mixtures of P407:P188 at weight ratios of 
1:2 and 1:1 gelled at 39.6°C ± 3.02°C and 37.6°C ± 1.78°C, 
respectively. In our study, the pH-sensitive liposomes did not 
significantly affect the gelation temperatures because when 
pH-sensitive liposomes were added to the thermosensitive 
gels, the gelation temperatures decreased slightly.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2625
mPEG-Hz-CHEMS-modified liposomal vaginal gelInternational Journal of Nanomedicine 2012:7
4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 600 400.0
85.0
86
88
90
92
94
96
98
100
102
104
106
108
110
112
114
116
118.0
cm−1
%
T
 
B
3808
3791
3745
3697
3663
3414
2927
2854
2435
2351
2318
1740
1466
1359
1243
1161
1074
951
860
666
523
4000.0 3200 3600 2800 2400 2000 1800 1600 1400 1200 1000 800 600 400.0
9.0
20
30
40
50
60
70
80
90
100
110
121.5
cm−1
%
T
C
3500
2888
1645
1467
1360
1344
1281
1243
1148
1114
1060
964
947
842
529
Figure 3 FT-IR spectra of blank gels (A), AC liposomes (B), AC dual-sensitive gels (C).
Abbreviation: AC, arctigenin.
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The pH-sensitive test for gel is clearly observed in 
  Figure 6. Arctigenin-loaded dual-sensitive liposome gels in 
the pH 5.0 study were completely eroded in 4 days, whereas 
the gels in the pH 7.4 and 9.0 studies eroded in around 
5 weeks. The presence of the gel phase and pH around body 
temperature (37°C) indicates that this material could be a 
promising candidate for a vaginal drug delivery system that 
can be formulated at room temperature and would form a gel 
in situ upon vaginal administration.
In vitro drug release
In vitro release experiments were performed at 37°C for 2 days 
in different pH buffers to study pH-dependent drug release 
behavior. The cumulative release of arctigenin, as shown in 
Figure 7, indicates that the arctigenin-loaded dual-sensitive 
liposome gel had prolonged release in pH 7.4 and 9.0 buffers. 
At pH 5.0, the gels showed constant release, and drug release 
was completed within 3 days. It has been reported previously 
that the rate of dissolution of gel is actually the controlling 
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Figure 4 DSC curves of AC (A), AC liposomes (B), AC dual-sensitive gels (C).
Abbreviation: AC, arctigenin.
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Figure 5 The sol-gel transition observation of AC dual-sensitive gels over the gelation temperature (A), gelation (B), and under the gelation temperature (C).
Abbreviation: AC, arctigenin.
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Figure 6 pH-sensitive profiles of AC dual-sensitive gels (n = 3).
Abbreviation: AC, arctigenin.
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Figure 7 In vitro release of AC dual-sensitive gels at pH 5.0, 7.4 and 9.0.
Abbreviation: AC, arctigenin.
factor in drug release.16 In this respect, the gel pH-sensitive 
pattern would explain the constant release at pH 5.0.14 The 
arctigenin-loaded dual-sensitive liposome gel looks interest-
ing for vaginal drug delivery in view of vaginal pH.
Cytotoxicity assay
The cytotoxicity of free arctigenin and the formulated arcti-
genin was investigated in HEK293 cells using MTT assays 
(Figure 8). Liposome gel was prepared by mixing P407 
and P188 as described earlier in this paper, and was diluted 
with phosphate-buffered saline (1:2 and 1:4, v/v), because 
polymer gels should be diluted with a proper dilution ratio 
or extracted in medium in the cytotoxicity tests of polymer 
gels.17 Cell viability (%) in the presence of free arctigenin, 
arctigenin-loaded pH-sensitive liposomes, arctigenin-loaded 
dual-sensitive liposome gel, diluted samples of arctigenin-
loaded dual-sensitive liposome gel with phosphate-buffered 
saline (1:2 and 1:4, v/v), and phosphate-buffered saline alone 
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were 46.8 ± 2.6, 68.8 ± 3.7, 58.2 ± 4.1, 72.1 ± 3.6, 78.5 ± 4.0, 
73.6 ± 3.8, and 76.3 ± 3.4, respectively. Arctigenin encapsu-
lated in pH-sensitive liposomes or arctigenin-loaded dual-
sensitive liposome gel was less toxic than free arctigenin. 
Furthermore, the cell viability of diluted arctigenin-loaded 
dual-sensitive liposome gel (1:2 and 1:4, v/v) was higher than 
for the intact dual-sensitive liposome gel. The cytotoxicity 
of free arctigenin in diluted gels (1:4 in phosphate-buffered 
saline) was also lower than for free arctigenin. Intact lipo-
some gel without dilution appears to be somewhat toxic com-
pared with arctigenin loaded into liposomes due to oxygen 
deficiency produced by the thickness of the gels.
Conclusion
In this work, we have prepared a thermosensitive and pH-
sensitive gel formulation for vaginal administration using 
novel cleavable mPEG-Hz-CHEMS. A dual-sensitive lipo-
some gel with high encapsulation efficiency of arctigenin 
was formed and improved the solubility of arctigenin. The 
dual-sensitive liposome gel with a sol-gel transition at body 
temperature was degraded in a pH-dependent manner which 
was stable for a long period of time at neutral and basic pH, 
but cleavable under acidic conditions (pH 5.0). The arcti-
genin encapsulated in the dual-sensitive liposome gels was 
stable and less toxic than arctigenin loaded into pH-sensitive 
  liposomes. These results suggest that a vaginal gel containing 
arctigenin would be useful for effective and convenient treat-
ment of vaginal candidiasis with reduced toxicity, and may be 
helpful in developing effective pharmaceutical formulations 
for vaginal delivery of hydrophobic drugs.
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